ArticleBMC infectious diseases2025
Catheter-associated urinary tract infections in the intensive care unit during and after the COVID- 19 pandemic.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Distribution of Uropathogens and Molecular Characterisation of Virulence Genes of UropathogenicPathogens (Basel, Switzerland) · 2026Article
- Reducing catheter urinary tract infection risk through biofilm prevention: evidence-based strategies for urinary catheter management.Iranian journal of microbiology · 2026Article
- Development and internal validation of a clinical prediction model for postoperative urinary tract infection in older surgical patients: a retrospective cohort study.BMC geriatrics · 2026Article
- Catheter-Associated Candiduria: Aggregates, Microscopy, and CFU Variability.Mycopathologia · 2026Article
- Characteristics and outcomes of ICU patients with bacterial catheter-associated urinary tract infection.PloS one · 2026Article
- Impact of pathophysiologically relevant underlying disease burden on pathogen distribution and antimicrobial resistance in patients with device-associated urinary tract infections.Frontiers in cellular and infection microbiology · 2026Article
- Epidemiological and antimicrobial resistance profile of catheter-associated and non-catheter urinary tract infections in trauma patients (2017-2024).BMC infectious diseases · 2025Article
- Evaluating nursing interventions to prevent catheter-associated urinary tract infection in ICU patients: a quasi-experimental study.BMC nursing · 2025Article
- Graphene Nanoplatelet-Embedded Urinary Catheters for Enhanced Photothermal Sterilization Against Bacterial Infections.International journal of molecular sciences · 2025Article
- A novel intelligent approach for infection protection using a multidisciplinary collaboration in regional general hospitals.Scientific reports · 2025Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUrinary tract infections (UTIs) acquired in hospitals, particularly among patients in intensive care units (ICUs), are prevalent and represent a significant clinical issue as they are associated with increased patient morbidity, prolonged hospital stays, elevated healthcare costs, and antimicrobial resistance development.
methodsThis study was conducted in the ICU of the University Hospital in Wrocław, Poland, from January 1, 2020, to June 30, 2024, and included 2,751 patients. The aim was to evaluate the incidence, epidemiological, and microbiological characteristics, mortality rates, and prevention strategies of UTIs during and after COVID-19 pandemic.
resultsCatheter-Associated Urinary Tract Infection (CAUTI) (48 hours after admission) was recorded in 243/2751 (8.83%) patients, whereas UTI at admission was found in 63/2751 (2.3%). The mean CAUTI incidence rate (per 1,000 patient-days) was 6.99, 95% CI (6.13-7.85), whereas the mean CAUTI incidence density (per 1,000 urinary catheter days) was 7.04, 95% CI (6.18-7.91). CAUTI was significantly more frequent in females (12.32%) than in males (6.85%), p = 0.0000008, and in internal-medical patients (14.07%) compared to surgical patients (6.45%), p < 0.000001. The mean CAUTI density during the pandemic equaled 8.03, 95% CI (6.46-9.60) and was greater than in the post-pandemic period 6.25, 95% CI (5.34-7.17), p = 0.051. No statistically significant difference was observed in CAUTI incidence between COVID-positive 27/264 (10.23%) and COVID-negative 83/904 (9.18%) patients, p = 0.942. The most frequently identified pathogen in CAUTI was Klebsiella pneumoniae ESBL/MBL, whereas in UTI at admission, it was Escherichia coli. The percentage of alert pathogens among CAUTI etiological factors was significantly higher during the pandemic 72/116 (62.07%), compared to the post-pandemic period 62/143 (43.36%), p = 0.002. There was no statistically significant difference in mortality between CAUTI patients 56/207 (27.05%) and patients without CAUTI 810/2,544 (31.84%), p = 0.119.
conclusionAlthough there were no statistically significant differences observed in CAUTI incidence between COVID-positive and COVID-negative patients, CAUTI remains a significant challenge in the ICU setting, with particularly elevated risks among female and internal-medical patients. Consistent monitoring of CAUTI, implementation, evaluation of preventive measures, and ongoing assessment are essential for improving clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.